Consistent with this, the more aggressive subgroups of medulloblastomas (molecular subgroups 3 and 4) and gliomas (GBMs, especially mesenchymal GBM) have lower PID1 mRNA compared to more favorable medulloblastomas and gliomas7. Here, PID1 is linked to central nervous system cancer.